- Home
- INBK vs KROS Comparison
INBK vs KROS Comparison
Compare INBK & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INBK | KROS |
|---|---|---|
| Founded | 1999 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 255.0M | 222.7M |
| IPO Year | 2013 | 2020 |
Fundamental Metrics
Financial Performance| Metric | INBK | KROS |
|---|---|---|
| Price | $25.29 | $10.30 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 7 |
| Target Price | ★ $31.00 | $19.83 |
| AVG Volume (30 Days) | 36.9K | ★ 168.9K |
| Earning Date | 10-29-2026 | 11-05-2026 |
| Dividend Yield | ★ 0.94% | N/A |
| EPS Growth | N/A | ★ 146.00 |
| EPS | ★ 1.10 | N/A |
| Revenue | $11,541,000.00 | ★ $243,864,000.00 |
| Revenue This Year | $18.83 | N/A |
| Revenue Next Year | $12.94 | N/A |
| P/E Ratio | $23.16 | ★ N/A |
| Revenue Growth | ★ 101.84 | N/A |
| 52 Week Low | $17.05 | $8.98 |
| 52 Week High | $31.09 | $22.55 |
Technical Indicators
Market Signals| Indicator | INBK | KROS |
|---|---|---|
| Relative Strength Index (RSI) | 42.60 | 45.34 |
| Support Level | $25.08 | N/A |
| Resistance Level | $26.09 | $11.86 |
| Average True Range (ATR) | 0.81 | 0.70 |
| MACD | -0.08 | -0.08 |
| Stochastic Oscillator | 14.44 | 43.10 |
Price Performance
Historical ComparisonAbout INBK First Internet Bancorp
First Internet Bancorp is a bank holding company. Through its subsidiaries, it provides commercial real estate (CRE) lending, including nationwide single tenant lease financing and commercial and industrial (C&I) lending, including business banking or treasury management services. The company offers its products and services through the internet and does not have any branches. With operations organized into a single segment called the Commercial Banking segment, it also provides retail banking services.
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.